Stockreport

Akari Therapeutics Reports Second Quarter 2019 Financial Results And Highlights Recent Clinical Progress

Akari Therapeutics Plc - American Depositary Shares  (AKTX) 
US:NASDAQ Investor Relations: investor.akaritx.com/investor-relations
PDF - Positive early safety and efficacy data with nomacopan Phase II clinical study in patients with mild-to-moderate bullous pemphigoid (BP) announced April 2019P [Read more]